Skip to main content

Table 1 Published reports of genomic alterations identified by comparative genomic hybridization in lobular carcinoma

From: Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer

 

Cases studied

 

Noted lobular-specific alterations

 

Reference

ALH/LCIS

Invasive

Other

Type of CGH

Gain

Loss

Observations

Lu and coworkers [41]

ALH and LCIS

IBC (adjacent in 6 cases)

 

Chromosomal

6q

16p, 16q, 17p, and 22q

Alterations were found at a similar high frequency in LCIS and ALH

Buerger and coworkers [45]

LCIS

ILC (adjacent LCIS in 4 cases)

DCIS

Chromosomal

1q

16q

LCIS characterized by low average rate of copy number changes; no evidence of amplification in LCIS

Gunther and coworkers [46]

 

ILC and IDC

 

Chromosomal

 

16q, 17q, and 22

Lower frequency of gain at 8q in ILC compared with IDC; changes of equal frequency include gain at 1q, and loss at 19p and parts of 1p and 11q

Weber-Mangal and coworkers [47]

 

ILC and IDC

IBC

Chromosomal

1q, 8q, and 11q

16q, 17p, and 22q

Lobular alterations were identified in a table of alterations; however, the study investigated alterations in breast cancer in general

Nishizaki and coworkers [48]

 

ILC and IDC

 

Chromosomal

1q

16q

Compared ILC with IDC; IDC had higher frequency of gain at 8q and 20q

Etzell and coworkers [49]

LCIS

  

Chromosomal

1q

8p, 12q24, 16q, and 17p

Correlated 16q loss with loss of expression of E-cadherin by immunohistochemistry

Mastracci and coworkers [4]

ALH and LCIS

  

SMRT BAC-array

2p11.2 and 20q13.13

7p11.2, 16q21-q23.1, 19q13.2, and 22q11.1

Alterations found in common between ALH and LCIS; also identified changes that were specific to either ALH or LCIS

Loo and coworkers [38]

ILC

IDC

 

BAC-array

1q32, 8p23, 11q13, and 11q14

16q23 and 16q24

Found differences between ILC and IDC, stratified by histologic type and estrogen receptor status

Hwang and coworkers [42]

LCIS

ILC (synchronous)

 

BAC-array

1q

11q11-q13, 11q14-qter, and 16q

Clonality was suggested for the genetic relationship between LCIS and ILC

Nyante and coworkers [43]

LCIS

ILC

DCIS

BAC-array

 

1p, 16q, and 17p/q

A different profile was identified for DCIS

Morandi and coworkers [44]

 

ILC

 

Oligo-array

1p, 2q, 3p, 6p, 16p, 19p, and 21q

16q and 19q

Lobular neoplastic lesions are genetically related to ILC and can be categorized as precursors

Reis-Filho and coworkers [50]

 

ILC

 

High-resolution CGH and array-CGH

1q, 5p, 7q, 11p, 11q, 12q, 14q, 16p, 18p, 19p+q, and 20p+q

11q, 13q, 16q, 18q, and Xq

Lobular carcinomas have greater genetic complexity and a higher number of recurrent genomic changes than previously reported with other techniques

Roylance and coworkers [51]

 

ILC and IDC

 

16q BAC-array

 

16q (whole chromosome arm)

Alterations on 16q are common to both IDC and ILC; higher grade IDCs have more complex changes on 16q

  1. The 'cases studied' column notes the breast lesion investigated in each study, i.e. ALH/LCIS, Invasive carcinoma or other breast lesions. The 'noted lobular-specific alterations' column notes the chromosomal gains and losses identified in each study. ALH, atypical lobular hyperplasia; BAC, bacterial artificial chromosome; DCIS, ductal carcinoma in situ; IBC, invasive breast cancer; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma; LCIS, lobular carcinoma in situ ; LN, lobular neoplasia; SMRT, submegabase resolution tiling array.